SUPREMEX INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.8 CAD | +0.53% |
|
+0.53% | -11.01% |
| 05-09 | Supremex Seeks Accretive Acquisitions and Investments | CI |
| 05-09 | Transcript : Supremex Inc., Q1 2024 Earnings Call, May 09, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The stock, which is currently worth 2024 to 0.58 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Paper Products
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -11.01% | 69.27M | - | ||
| -3.17% | 18.69B | B | ||
| +3.34% | 11.85B | A- | ||
| +2.78% | 10.2B | A | ||
| -1.39% | 6.33B | B | ||
| +6.18% | 4.75B | A- | ||
| +16.00% | 3.86B | A- | ||
| +85.49% | 3.03B | B- | ||
| +10.48% | 2.92B | B+ | ||
| +9.54% | 1.8B | - |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SXP Stock
- Ratings Supremex Inc.
